Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3065

Actual shortage: 231 (8%)
Anticipated shortage: 16 (1%)
Avoided shortage: 9 (0%)
Resolved: 2809 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-14 159719
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-22 159722
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-11-07 159725
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-27 2022-06-03 161442
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2022-06-12 2022-07-28 162475
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-11 2022-08-12 164378
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165317
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165322
APO-OXYCODONE CR 5.0MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-09-23 165332
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-08-19 2022-10-14 167421
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-20 2023-02-09 175312
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-27 2023-01-06 175895
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-02-02 177600
APO-OXYCODONE CR 20.0MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-01-26 177612
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2022-12-16 177672
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-20 178775
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179444
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179447

Showing 2921 to 2940 of 3065

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SUCRALFATE - TAB 1G 1G TABLET Discontinued 2018-09-10 2018-09-15 61033
APO-TADALAFIL 20MG TABLET Discontinued 2018-09-10 2019-02-13 61045
APO-TAMOX TAB 20MG 20MG TABLET Discontinued 2018-09-10 2019-09-12 61050
APO-ACETAMINOPHEN 325MG TABLET Discontinued 2018-10-11 2018-10-11 63845
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2018-10-25 2018-10-25 65585
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-11-19 2018-11-19 67146
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2019-01-02 2019-01-02 70787
APO-IBUPROFEN 300MG TABLET Discontinued 2019-01-02 2019-01-02 70793
APO-IBUPROFEN 400MG TABLET Discontinued 2019-01-02 2019-01-02 70799
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-02-21 70802
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-07-13 70805
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-08-08 70807
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-PRAVASTATIN 20MG TABLET Discontinued 2019-01-03 2019-01-03 71014
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
APO-ALENDRONATE 10MG TABLET To be discontinued 2019-01-03 2019-12-20 71026
APO-VALSARTAN/HCTZ 12.5MG 160MG TABLET Discontinued 2019-01-03 2019-01-03 71054
APO-ZOLMITRIPTAN 2.5MG TABLET Discontinued 2019-01-03 2019-01-03 71072
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2019-01-03 2019-01-03 71101

Showing 281 to 300 of 356